AMN Healthcare Services Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by AMN Healthcare Services, Inc. on December 12, 2012, reporting events that occurred on December 10, 2012. The filing addresses corporate governance changes under Item 5.02 regarding the appointment of a new director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters.
Material Changes
The Board of Directors unanimously voted to increase the Board size to eight members and appointed Mark Foletta as a new director, effective December 10, 2012. Mr. Foletta was also appointed to the Audit Committee on the same date.
Management Commentary and Compensation
Mr. Foletta brings significant financial experience, having previously served as CFO for Amylin Pharmaceuticals, Inc. and holding senior roles at Triton Group and Intermark. His compensation package includes:
- 4,092 restricted stock units with an aggregate grant date fair value of $45,749, vesting on the first anniversary of the grant date.
- A pro-rated annual retainer of $16,667 based on anticipated service months until the next annual meeting.
- No separate meeting fees.
Investor Verification Checklist
- Confirm the effective date of Mark Foletta's directorship and Audit Committee appointment (December 10, 2012).
- Verify the vesting schedule and fair value of the 4,092 restricted stock units granted.
- Review the total Board composition to confirm the increase to eight members.
- Check for any subsequent filings regarding Mr. Foletta's continued service or resignation.